Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Variations in Care for Breastfed Infants Admitted to US Children's Hospitals: A Multicenter Survey of Inpatient Providers.

Bochner RE, Kuroki R, Lui K, Russell CJ, Rackovsky E, Piper L, Ban K, Yang K, Mandal P, Mackintosh L, Mirzaian CB, Gross E.

Hosp Pediatr. 2019 Dec 11. pii: hpeds.2019-0199. doi: 10.1542/hpeds.2019-0199. [Epub ahead of print]

PMID:
31826917
2.

HA stability regulates H1N1 influenza virus replication and pathogenicity in mice by modulating type I interferon responses in dendritic cells.

Russier M, Yang G, Briard B, Meliopoulos V, Cherry S, Kanneganti TD, Schultz-Cherry S, Vogel P, Russell CJ.

J Virol. 2019 Nov 6. pii: JVI.01423-19. doi: 10.1128/JVI.01423-19. [Epub ahead of print]

PMID:
31694942
3.

Development of Chronic Pseudomonas aeruginosa-Positive Respiratory Cultures in Children with Tracheostomy.

Russell CJ, Simon TD, Neely MN.

Lung. 2019 Dec;197(6):811-817. doi: 10.1007/s00408-019-00285-6. Epub 2019 Oct 31.

PMID:
31673781
4.

A cross-sectional study of predatory publishing emails received by career development grant awardees.

Wilkinson TA, Russell CJ, Bennett WE, Cheng ER, Carroll AE.

BMJ Open. 2019 May 19;9(5):e027928. doi: 10.1136/bmjopen-2018-027928.

5.

Early Use of Anti-influenza Medications in Hospitalized Children With Tracheostomy.

Miyakawa R, Barreto NB, Kato RM, Neely MN, Russell CJ.

Pediatrics. 2019 Mar;143(3). pii: e20182608. doi: 10.1542/peds.2018-2608.

PMID:
30814271
6.

Complication Versus Consequence: Defining Device-Related Outcomes in Children With Medical Complexity.

Russell CJ.

Hosp Pediatr. 2019 Jan;9(1):70-71. doi: 10.1542/hpeds.2018-0230. Epub 2018 Dec 10. No abstract available.

PMID:
30530804
7.

Directed Evolution of an Influenza Reporter Virus To Restore Replication and Virulence and Enhance Noninvasive Bioluminescence Imaging in Mice.

Cai H, Liu M, Russell CJ.

J Virol. 2018 Jul 31;92(16). pii: e00593-18. doi: 10.1128/JVI.00593-18. Print 2018 Aug 15.

8.

Factors Associated With Length of Stay and 30-Day Revisits in Pediatric Acute Pancreatitis.

Gay AC, Barreto NB, Schrager SM, Russell CJ.

J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):e30-e35. doi: 10.1097/MPG.0000000000002033.

9.

Ferrets as Models for Influenza Virus Transmission Studies and Pandemic Risk Assessments.

Belser JA, Barclay W, Barr I, Fouchier RAM, Matsuyama R, Nishiura H, Peiris M, Russell CJ, Subbarao K, Zhu H, Yen HL.

Emerg Infect Dis. 2018 Jun;24(6):965-971. doi: 10.3201/eid2406.172114.

10.

Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk.

Russell CJ, Hu M, Okda FA.

Trends Microbiol. 2018 Oct;26(10):841-853. doi: 10.1016/j.tim.2018.03.005. Epub 2018 Apr 19. Review.

11.

Scalable total synthesis and comprehensive structure-activity relationship studies of the phytotoxin coronatine.

Littleson MM, Baker CM, Dalençon AJ, Frye EC, Jamieson C, Kennedy AR, Ling KB, McLachlan MM, Montgomery MG, Russell CJ, Watson AJB.

Nat Commun. 2018 Mar 16;9(1):1105. doi: 10.1038/s41467-018-03443-1.

12.

Length of Stay and Hospital Revisit After Bacterial Tracheostomy-Associated Respiratory Tract Infection Hospitalizations.

Russell CJ, Mamey MR, Koh JY, Schrager SM, Neely MN, Wu S.

Hosp Pediatr. 2018 Jan 16. pii: hpeds.2017-0106. doi: 10.1542/hpeds.2017-0106. [Epub ahead of print]

13.

Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles.

Russell CJ, Simões EAF, Hurwitz JL.

Viral Immunol. 2018 Mar;31(2):133-141. doi: 10.1089/vim.2017.0137. Epub 2018 Jan 11. Review.

14.

Risk factors for hospitalizations due to bacterial respiratory tract infections after tracheotomy.

Russell CJ, Thurm C, Hall M, Simon TD, Neely MN, Berry JG.

Pediatr Pulmonol. 2018 Mar;53(3):349-357. doi: 10.1002/ppul.23938. Epub 2018 Jan 4.

15.

Factors associated with 30-day all-cause hospital readmission after tracheotomy in pediatric patients.

Yu H, Mamey MR, Russell CJ.

Int J Pediatr Otorhinolaryngol. 2017 Dec;103:137-141. doi: 10.1016/j.ijporl.2017.10.019. Epub 2017 Oct 18.

16.

A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.

Marathe BM, Mostafa HH, Vogel P, Pascua PNQ, Jones JC, Russell CJ, Webby RJ, Govorkova EA.

Antiviral Res. 2017 Dec;148:20-31. doi: 10.1016/j.antiviral.2017.10.021. Epub 2017 Oct 31.

PMID:
29100887
17.

Dynamics of Sendai Virus Spread, Clearance, and Immunotherapeutic Efficacy after Hematopoietic Cell Transplant Imaged Noninvasively in Mice.

Mostafa HH, Vogel P, Srinivasan A, Russell CJ.

J Virol. 2018 Jan 2;92(2). pii: e01705-17. doi: 10.1128/JVI.01705-17. Print 2018 Jan 15.

18.

Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection.

Pascua PNQ, Mostafa HH, Marathe BM, Vogel P, Russell CJ, Webby RJ, Govorkova EA.

Sci Rep. 2017 Aug 4;7(1):7345. doi: 10.1038/s41598-017-07433-z.

19.

A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.

Russell CJ, Jones BG, Sealy RE, Surman SL, Mason JN, Hayden RT, Tripp RA, Takimoto T, Hurwitz JL.

Virology. 2017 Sep;509:60-66. doi: 10.1016/j.virol.2017.05.021. Epub 2017 Jun 9.

20.

Pseudomonas aeruginosa and post-tracheotomy bacterial respiratory tract infection readmissions.

Russell CJ, Simon TD, Mamey MR, Newth CJL, Neely MN.

Pediatr Pulmonol. 2017 Sep;52(9):1212-1218. doi: 10.1002/ppul.23716. Epub 2017 Apr 25.

21.

H1N1 influenza viruses varying widely in hemagglutinin stability transmit efficiently from swine to swine and to ferrets.

Russier M, Yang G, Marinova-Petkova A, Vogel P, Kaplan BS, Webby RJ, Russell CJ.

PLoS Pathog. 2017 Mar 10;13(3):e1006276. doi: 10.1371/journal.ppat.1006276. eCollection 2017 Mar.

22.

Care Variations and Outcomes for Children Hospitalized With Bacterial Tracheostomy-Associated Respiratory Infections.

Russell CJ, Mack WJ, Schrager SM, Wu S.

Hosp Pediatr. 2017 Jan;7(1):16-23. doi: 10.1542/hpeds.2016-0104.

23.

Hot topics, urgent priorities, and ensuring success for racial/ethnic minority young investigators in academic pediatrics.

Flores G, Mendoza FS, Fuentes-Afflick E, Mendoza JA, Pachter L, Espinoza J, Fernandez CR, Arnold DD, Brown NM, Gonzalez KM, Lopez C, Owen MC, Parks KM, Reynolds KL, Russell CJ.

Int J Equity Health. 2016 Dec 9;15(1):201.

24.

Drivers of airborne human-to-human pathogen transmission.

Herfst S, Böhringer M, Karo B, Lawrence P, Lewis NS, Mina MJ, Russell CJ, Steel J, de Swart RL, Menge C.

Curr Opin Virol. 2017 Feb;22:22-29. doi: 10.1016/j.coviro.2016.11.006. Epub 2016 Dec 2. Review.

25.

Viral factors in influenza pandemic risk assessment.

Lipsitch M, Barclay W, Raman R, Russell CJ, Belser JA, Cobey S, Kasson PM, Lloyd-Smith JO, Maurer-Stroh S, Riley S, Beauchemin CA, Bedford T, Friedrich TC, Handel A, Herfst S, Murcia PR, Roche B, Wilke CO, Russell CA.

Elife. 2016 Nov 11;5. pii: e18491. doi: 10.7554/eLife.18491.

26.

Influenza Virus Overcomes Cellular Blocks To Productively Replicate, Impacting Macrophage Function.

Marvin SA, Russier M, Huerta CT, Russell CJ, Schultz-Cherry S.

J Virol. 2017 Jan 3;91(2). pii: e01417-16. doi: 10.1128/JVI.01417-16. Print 2017 Jan 15.

27.

Factors Associated With the Prophylactic Prescription of a Bowel Regimen to Prevent Opioid-Induced Constipation.

Chen NY, Nguyen E, Schrager SM, Russell CJ.

Hosp Pediatr. 2016 Nov;6(11):677-683.

28.

Focal adhesion kinase (FAK) regulates polymerase activity of multiple influenza A virus subtypes.

Elbahesh H, Bergmann S, Russell CJ.

Virology. 2016 Dec;499:369-374. doi: 10.1016/j.virol.2016.10.002. Epub 2016 Oct 13.

29.

Risk factors for overnight respiratory events following sedation for magnetic resonance imaging in children with sleep apnea.

Trost MJ, Cowell M, Cannon J, Mitchell K, Waloff K, Avila H, Chand S, Russell CJ.

Sleep Breath. 2017 Mar;21(1):137-141. doi: 10.1007/s11325-016-1410-4. Epub 2016 Sep 28.

PMID:
27683261
30.
31.

Novel Highly Pathogenic Avian A(H5N2) and A(H5N8) Influenza Viruses of Clade 2.3.4.4 from North America Have Limited Capacity for Replication and Transmission in Mammals.

Kaplan BS, Russier M, Jeevan T, Marathe B, Govorkova EA, Russell CJ, Kim-Torchetti M, Choi YK, Brown I, Saito T, Stallknecht DE, Krauss S, Webby RJ.

mSphere. 2016 Apr 6;1(2). pii: e00003-16. doi: 10.1128/mSphere.00003-16. eCollection 2016 Mar-Apr.

32.

The use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: a systematic review.

Russell CJ, Shiroishi MS, Siantz E, Wu BW, Patino CM.

BMC Pulm Med. 2016 Mar 8;16:40. doi: 10.1186/s12890-016-0202-8. Review.

33.

Molecular requirements for a pandemic influenza virus: An acid-stable hemagglutinin protein.

Russier M, Yang G, Rehg JE, Wong SS, Mostafa HH, Fabrizio TP, Barman S, Krauss S, Webster RG, Webby RJ, Russell CJ.

Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):1636-41. doi: 10.1073/pnas.1524384113. Epub 2016 Jan 25.

34.

Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses.

Russell CJ, Hurwitz JL.

Expert Rev Vaccines. 2016;15(2):189-200. doi: 10.1586/14760584.2016.1114418. Epub 2015 Dec 9. Review.

35.

Palladium(II)-Catalyzed Synthesis of Sulfinates from Boronic Acids and DABSO: A Redox-Neutral, Phosphine-Free Transformation.

Deeming AS, Russell CJ, Willis MC.

Angew Chem Int Ed Engl. 2016 Jan 11;55(2):747-50. doi: 10.1002/anie.201508370. Epub 2015 Nov 24.

36.

Changes to the dynamic nature of hemagglutinin and the emergence of the 2009 pandemic H1N1 influenza virus.

Yoon SW, Chen N, Ducatez MF, McBride R, Barman S, Fabrizio TP, Webster RG, Haliloglu T, Paulson JC, Russell CJ, Hertz T, Ben-Tal N, Webby RJ.

Sci Rep. 2015 Aug 13;5:12828. doi: 10.1038/srep12828.

37.

Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck.

Zaraket H, Baranovich T, Kaplan BS, Carter R, Song MS, Paulson JC, Rehg JE, Bahl J, Crumpton JC, Seiler J, Edmonson M, Wu G, Karlsson E, Fabrizio T, Zhu H, Guan Y, Husain M, Schultz-Cherry S, Krauss S, McBride R, Webster RG, Govorkova EA, Zhang J, Russell CJ, Webby RJ.

Nat Commun. 2015 Apr 8;6:6553. doi: 10.1038/ncomms7553.

38.

A critical appraisal of ventilation tube insertion in children with cleft palate--reply.

Smillie I, Robertson S, Yule A, Wynne DM, Russell CJ.

JAMA Otolaryngol Head Neck Surg. 2015 Feb;141(2):190. doi: 10.1001/jamaoto.2015.38. No abstract available.

PMID:
25695363
40.

Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children.

Adderson E, Branum K, Sealy RE, Jones BG, Surman SL, Penkert R, Freiden P, Slobod KS, Gaur AH, Hayden RT, Allison K, Howlett N, Utech J, Allay J, Knight J, Sleep S, Meagher MM, Russell CJ, Portner A, Hurwitz JL.

Clin Vaccine Immunol. 2015 Mar;22(3):298-303. doi: 10.1128/CVI.00618-14. Epub 2014 Dec 31.

41.

Socioeconomic influence on orofacial cleft patient care.

Smillie I, Yong K, Harris K, Wynne DM, Russell CJ.

Scott Med J. 2015 May;60(2):70-4. doi: 10.1177/0036933014564133. Epub 2014 Dec 12.

PMID:
25504476
42.

Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.

Zhan X, Slobod KS, Jones BG, Sealy RE, Takimoto T, Boyd K, Surman S, Russell CJ, Portner A, Hurwitz JL.

Int Immunol. 2015 May;27(5):229-36. doi: 10.1093/intimm/dxu107. Epub 2014 Dec 4.

43.

Combining organometallic reagents, the sulfur dioxide surrogate DABSO, and amines: a one-pot preparation of sulfonamides, amenable to array synthesis.

Deeming AS, Russell CJ, Willis MC.

Angew Chem Int Ed Engl. 2015 Jan 19;54(4):1168-71. doi: 10.1002/anie.201409283. Epub 2014 Nov 27.

44.

Complications of ventilation tube insertion in children with and without cleft palate: a nested case-control comparison.

Smillie I, Robertson S, Yule A, Wynne DM, Russell CJ.

JAMA Otolaryngol Head Neck Surg. 2014 Oct;140(10):940-3. doi: 10.1001/jamaoto.2014.1657.

PMID:
25171763
45.

Acid-induced membrane fusion by the hemagglutinin protein and its role in influenza virus biology.

Russell CJ.

Curr Top Microbiol Immunol. 2014;385:93-116. doi: 10.1007/82_2014_393. Review.

PMID:
25007844
46.

Care of children with medical complexity in the hospital setting.

Russell CJ, Simon TD.

Pediatr Ann. 2014 Jul;43(7):e157-62. doi: 10.3928/00904481-20140619-09. Review.

PMID:
24977678
47.

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.

Jones BG, Sealy RE, Surman SL, Portner A, Russell CJ, Slobod KS, Dormitzer PR, DeVincenzo J, Hurwitz JL.

Vaccine. 2014 May 30;32(26):3264-73. doi: 10.1016/j.vaccine.2014.03.088. Epub 2014 Apr 14.

48.

Novel roles of focal adhesion kinase in cytoplasmic entry and replication of influenza A viruses.

Elbahesh H, Cline T, Baranovich T, Govorkova EA, Schultz-Cherry S, Russell CJ.

J Virol. 2014 Jun;88(12):6714-28. doi: 10.1128/JVI.00530-14. Epub 2014 Apr 2.

49.

DABSO-based, three-component, one-pot sulfone synthesis.

Deeming AS, Russell CJ, Hennessy AJ, Willis MC.

Org Lett. 2014 Jan 3;16(1):150-3. doi: 10.1021/ol403122a. Epub 2013 Dec 5.

50.

Mode of parainfluenza virus transmission determines the dynamics of primary infection and protection from reinfection.

Burke CW, Bridges O, Brown S, Rahija R, Russell CJ.

PLoS Pathog. 2013;9(11):e1003786. doi: 10.1371/journal.ppat.1003786. Epub 2013 Nov 21.

Supplemental Content

Loading ...
Support Center